Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

The public health concern caused by influenza B virus is often overlooked, yet represents a significant global burden. Here, the authors evaluate the cellular and humoral immune responses of multivalent vaccine candidates, based on the lipid nanoparticle-encapsulated nucleoside-modified mRNA platfor...

Full description

Bibliographic Details
Main Authors: Norbert Pardi, Juan Manuel Carreño, George O’Dell, Jessica Tan, Csaba Bajusz, Hiromi Muramatsu, Willemijn Rijnink, Shirin Strohmeier, Madhumathi Loganathan, Dominika Bielak, Molly M. H. Sung, Ying K. Tam, Florian Krammer, Meagan McMahon
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-32149-8

Internet

https://doi.org/10.1038/s41467-022-32149-8

Similar Items